01 1ACS Dobfar S.p.A
02 1Shandong Anhong Pharmaceutical Co., Ltd.
03 2Sumitomo Pharma Co., Ltd.
01 2MEROPENEM
02 1Meropenem
03 1Meropenem with sodium carbonate
01 1China
02 1Italy
03 2Japan
NDC Package Code : 52946-0839
Start Marketing Date : 2009-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-016
Start Marketing Date : 2014-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38217-0020
Start Marketing Date : 2018-07-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (12kg/12kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38217-0021
Start Marketing Date : 1996-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5.9kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Meropenem manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meropenem, including repackagers and relabelers. The FDA regulates Meropenem manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meropenem API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meropenem manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meropenem supplier is an individual or a company that provides Meropenem active pharmaceutical ingredient (API) or Meropenem finished formulations upon request. The Meropenem suppliers may include Meropenem API manufacturers, exporters, distributors and traders.
click here to find a list of Meropenem suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meropenem as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meropenem API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meropenem as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meropenem and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meropenem NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meropenem suppliers with NDC on PharmaCompass.
We have 3 companies offering Meropenem
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
